Clinical Trials for Lung Adenocarcinoma

Find clinical trials for lung adenocarcinoma. Discover research opportunities and treatment options in your area.

38 Active Trials Found

Showing 38 trials on this page

Page 2 of 2

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

NCT ID: NCT06602661

This clinical trial is studying whether special staplers, called reinforced staplers, can help prevent a common problem after lung surgery known as Prolonged Air Leak (PAL). PAL can lead to longer ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Surrey, B.C, Canada

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

NCT ID: NCT04937283

This clinical trial is comparing two types of surgery for patients with small lung tumors called lung adenocarcinoma, specifically tumors that are 2 cm or smaller. The two surgical options being co...

Phase: NA Type: interventional Locations: Hangzhou, Zhejiang, China, Shanghai, Shanghai, China +14 more

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

NCT ID: NCT05717803

The ECTOP-1012 clinical trial is studying a surgical procedure called segmentectomy to treat a specific type of lung cancer called ground glass-dominant invasive lung adenocarcinoma. This trial aim...

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

NCT ID: NCT05266846

This clinical trial is studying a combination of three treatments—Pembrolizumab, Bevacizumab, and chemotherapy—to see if they can help patients with a specific type of lung cancer called advanced A...

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

NCT ID: NCT05528458

This clinical trial is looking at a medication called osimertinib to see if it can help prevent the growth of any remaining ground-glass nodules (GGNs) in the lungs after surgery for a specific typ...

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

NCT ID: NCT06255197

This clinical trial is studying patients who have had surgery to remove lung cancer, including different types like lung adenocarcinoma and small-cell lung cancer. The goal is to collect and analyz...

Type: observational Locations: Beijing, Beijing, China

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

NCT ID: NCT05526573

This clinical trial is studying a new tool called an ultrathin bronchoscope (UB) to help doctors diagnose lung problems, specifically in hard-to-reach areas of the lungs known as peripheral lung le...

Type: observational Locations: Ancona, , Italy, Reggio Emilia, , Italy +1 more

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

NCT ID: NCT06031181

The ECTOP-1019 clinical trial is studying a surgical procedure called sublobar resection for patients with a type of lung cancer known as adenocarcinoma in situ (AIS) or minimally invasive adenocar...

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma

NCT ID: NCT06104709

This clinical trial is studying the effects of a treatment called cryoablation on patients with lung adenocarcinoma, a type of lung cancer. Cryoablation involves freezing cancer cells to kill them,...

Not yet recruiting

Type: observational

AMT-151 in Patients With Selected Advanced Solid Tumours

NCT ID: NCT05498597

This clinical trial is investigating a new treatment called AMT-151 for patients with certain advanced cancers, including various types of ovarian, endometrial, lung, breast, and pancreatic cancers...

Phase: PHASE1 Type: interventional Locations: Fuzhou, Fujian, China, Sydney, New South Wales, Australia +7 more

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

NCT ID: NCT06056115

This clinical trial is investigating the effectiveness and safety of a medication called Tislelizumab, combined with chemotherapy, for treating patients with lung adenocarcinoma that has spread to ...

Phase: NA Type: interventional Locations: Shijiazhuang, Hebei, China

Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)

NCT ID: NCT06031246

The clinical trial ECTOP-1018 is studying a surgical procedure called selective lymph node dissection for patients with a specific type of lung cancer known as invasive non-small cell lung cancer (...

Phase: PHASE3 Type: interventional Locations: Shanghai, Please Select, China

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

NCT ID: NCT05838053

This clinical trial is studying two surgical options for patients with a specific type of lung cancer called lung adenocarcinoma that is 2 centimeters or smaller. The goal is to determine whether a...

Type: observational Locations: Yangpu, Shanghai, China

Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015)

NCT ID: NCT05794711

The ECTOP-1015 clinical trial is studying a method to help doctors decide how to treat early-stage lung adenocarcinoma, a type of lung cancer. Specifically, the trial aims to compare two types of p...

Type: observational Locations: Shanghai, Shanghai, China

Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)

NCT ID: NCT05794724

The ECTOP-1016 clinical trial is studying a method to help doctors make better decisions during surgery for patients with early-stage lung adenocarcinoma, a type of lung cancer. The trial aims to c...

Type: observational Locations: Shanghai, Shanghai, China

A Single-arm Exploratory Study of Neoadjuvant Therapy

NCT ID: NCT05527808

This clinical trial is studying a new treatment approach for patients with lung adenocarcinoma, which is a type of lung cancer. The researchers want to see if combining a medication called Tisleizu...

Phase: NA Type: interventional Locations: Guangzhou, Please Select, China

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

NCT ID: NCT05537922

The I3LUNG clinical trial is focused on improving treatment for patients with advanced non-small cell lung cancer (NSCLC) by developing a new medical tool that can predict how well immunotherapy wi...

Type: observational Locations: Chicago, Illinois, United States, Athens, , Greece +2 more

Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)

NCT ID: NCT04965831

This clinical trial, called FRONT, is focused on testing a new medication called furmonertinib for patients with a specific type of lung cancer known as stage IIIA-IIIB lung adenocarcinoma. This tr...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions